SirTlab Corporation

Genetic Treatment for Age-related Diseases

Health Tech & Life Sciences
Active
Seed Ramat Gan Founded 2012
Website ↗
Total raised
$1.5M
Last: Equity crowdfunding 2025-05
Stage
Seed
Founded
2012
Headcount
6
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

SirTLab is the leader in Restoring SIRT6 Expression for Severe Liver Diseases and Diseases of Aging.

Sirtuin 6 (SIRT6) is a Key Regulator for Health in all cells. Levels of SIRT6 are reduced in liver diseases: NASH1, other cirrhosis, metabolic syndrome, acetaminophen toxicity.

SIRTLab patented SIRT6-mRNA-LNP2 for liver specific expression of SIRT6 is based on 18 years of research.

Funding history · 2 rounds · $1.5M total

2025-05
Equity crowdfunding $486K
2021-12
Undisclosed $156K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 Patents

Tags

anti-agingtherapeuticspharmaceuticalsgeneticspharma-companieschronic-patients